News by subject: Proxy/Proxy Vote

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively "HDF"), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. ("Enzo" or the "Company"), today issued the following statement...

Accenture has been notified that TRC Capital Investment Corporation ("TRC Capital") has made an unsolicited "mini-tender" offer to purchase up to 750,000 Class A ordinary shares of Accenture plc at an offer price of $199.38 per share in cash, which...

OncoSec Medical Incorporated (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today issued the following statement to its shareholders regarding Alpha Holdings, Inc.'s ("Alpha") January 27, 2020...

Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, today announces the information...

Alpha Holdings, Inc. (KOSDAQ: 117670) ("Alpha"), the largest stockholder of OncoSec Medical Incorporated ("OncoSec"), with an approximate 15.1% ownership stake, today announced that it has renewed its alternative financing proposal and provided a...

Maple Rock Capital Partners Inc. ("Maple Rock") announced today that it is ceasing to file reports in accordance with the alternative monthly reporting system under Part 4 of National Instrument 62-103 ? The Early Warning System and Related Take-Over...

Maple Rock Capital Partners Inc., owning approximately 22.1% of the subordinate voting shares of Optiva Inc. ("Optiva" or the "Company"), announces it, as investment manager of Maple Rock Master Fund LP, has requisitioned (the "Requisition")...

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively "HDF"), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. ("Enzo" or the "Company"), today sent a letter to shareholders...

Boxwood Merger Corp. ("Boxwood"), a special purpose acquisition company, today announced that it intends to convene and then adjourn, without conducting any other business, the adjourned special meeting in lieu of the 2019 annual meeting of...

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively "HDF"), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. ("Enzo" or the "Company"), today announced that Egan-Jones Proxy...

TEGNA Inc. today issued a letter to its shareholders highlighting TEGNA's successful strategic evolution as well as its recent strong performance and future growth opportunities in light of Standard General LP's nomination of four candidates for...

Enzo Biochem, Inc. , an integrated diagnostics and life sciences company focusing on delivering and applying advanced technology capabilities to produce affordable, reliable and fully-automated platforms and related products and services that enable...

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively "HDF"), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. ("Enzo" or the "Company"), today announced that a leading proxy...

Alpha Holdings, Inc. (KOSDAQ: 117670) ("Alpha"), the largest stockholder of OncoSec Medical Incorporated ("OncoSec"), with an approximate 15.1% ownership stake, today issued the following response to OncoSec's rejection of Alpha's superior financing...

OrbiMed Advisors LLC ("OrbiMed"), on behalf of its clients, has evaluated the Joint Proxy Statement/Prospectus for the proposed merger of Foamix Pharmaceuticals Ltd. ("Foamix") and Menlo Therapeutics Inc. ("Menlo"). After careful consideration and...

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively "HDF"), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. ("Enzo" or the "Company"), today announced that a leading proxy...

OncoSec Medical Incorporated (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that its Board of Directors (the "Board") has determined the Alpha Holdings, Inc. ("Alpha") proposal...

Hudson Executive Capital LP ("Hudson Executive"), a New York-based investment firm and the largest shareholder of USA Technologies, Inc. ("USAT" or the "Company") with beneficial ownership of approximately 16.3% of common stock, today announced that...

Insert new paragraph after the 1st paragraph under the "ADDITIONAL INFORMATION AND WHERE TO FIND IT" section of the release. The corrected release reads:  ALPHA HOLDINGS SENDS OPEN LETTER TO ONCOSEC STOCKHOLDERS ANSWERING QUESTIONS ON PROPOSED...

Alpha Holdings, Inc. (KOSDAQ: 117670) ("Alpha"), the largest stockholder of OncoSec Medical Incorporated ("OncoSec"), with an approximate 15.1% ownership stake, today announced that it has delivered a binding term sheet to the Board of Directors of...

Woodbridge Liquidation Trust today announced that it had issued a letter to the holders of its Class A Liquidation Trust Interests regarding the pending cash tender offer by Contrarian Liquidity Option, LLC to purchase 2,015,305 of the outstanding...

The Board of Directors of Enzo Biochem, Inc. , an integrated diagnostics and life sciences company focusing on delivering and applying advanced technology capabilities to produce affordable, reliable and fully-automated platforms and related products...

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively "HDF"), the beneficial owner of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. ("Enzo" or the "Company"), today released a detailed investor...

Funds advised by Elliott Advisors (UK) Limited (together "Elliott"), that collectively hold an economic interest in Altran Technologies SA ("Altran" or the "Company") representing nearly 14% of the share capital, today published a letter outlining...

Alpha Holdings, Inc. (KOSDAQ: 117670) ("Alpha"), the largest stockholder of OncoSec Medical Incorporated ("OncoSec"), with an approximate 15.1% ownership stake, today sent a letter to its fellow OncoSec stockholders in advance of the Company's...

OncoSec Medical Incorporated (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today issued the following letter to its shareholders. The full text of the letter and additional information can be...

Boxwood Merger Corp. ("Boxwood"), a special purpose acquisition company, today announced that it intends to convene and then adjourn, without conducting any other business, the adjourned special meeting in lieu of the 2019 annual meeting of...

MRMP-Managers LLC, NLS Advisory Group, Inc., Ned L. Sherwood, and Bradley M. Tirpak announced today that they have sent the following press release and announcement to shareholders of Barnwell Industries, Inc. ("Barnwell"). Dear Fellow Owner, In...

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively "HDF"), the beneficial owner of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. ("Enzo" or the "Company"), sent a detailed letter to shareholders...

Alpha Holdings, Inc. (KOSDAQ: 117670) ("Alpha"), the largest stockholder of OncoSec Medical Incorporated ("OncoSec"), with an approximate 15.1% ownership stake, today sent a letter to its fellow OncoSec stockholders in advance of the Company's...

Alpha Holdings, Inc. (KOSDAQ:117670) ("Alpha") today issued the following statement in response to a report by Institutional Shareholder Services ("ISS") regarding the vote on the proposed takeover of OncoSec Medical Incorporated ("OncoSec") by...

OncoSec Medical Incorporated (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that Institutional Shareholder Services Inc. ("ISS"), a leading proxy advisory firm that provides...

OncoSec Medical Incorporated , (the "Company" or "OncoSec") today issued the following response to the latest press release from Alpha Holdings, Inc. (Alpha): "Throughout its campaign to stop OncoSec's proposed strategic transaction (the...

Alpha Holdings, Inc. (KOSDAQ: 117670) ("Alpha"), the largest stockholder of OncoSec Medical Incorporated ("OncoSec"), with an approximate 15.1% ownership stake, today announced key terms of an alternate $30 million financing proposal it is willing...

OncoSec Medical Incorporated (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced the release of a detailed presentation highlighting the Company's strategic rationale ? and benefits for...

Cat Rock Capital Management LP (together with its affiliates, "Cat Rock Capital"), a long-term oriented investment firm and beneficial owner of approximately 17.7 million shares of the common stock of Just Eat plc ("Just Eat" or the "Company") (LSE:...

Eminence Capital, LP ("Eminence"), the beneficial owner of approximately 28.7 million ordinary shares of Just Eat plc ("Just Eat") (LON: JE), representing 4.21% of Just Eat's outstanding shares, today issued the following statement regarding the...

Alpha Holdings, Inc. (KOSDAQ: 117670) ("Alpha"), the largest stockholder of OncoSec Medical Incorporated ("OncoSec"), with an approximate 15.1% ownership stake, today delivered its presentation to Institutional Shareholder Services ("ISS") in...

Alpha Holdings, Inc. (KOSDAQ: 117670) ("Alpha"), the largest stockholder of OncoSec Medical Incorporated ("OncoSec"), with an approximate 15.1% ownership stake, today sent an open letter to its fellow OncoSec stockholders in advance of the Company's...

Driver Management Company LLC ("Driver" or "we"), the manager of an investment partnership that holds more than 5% of the outstanding shares of First United Corporation ("First United" or the "Company") , today made public a letter sent to the...

The Board of Directors of Argo Group International Holdings, Ltd. ("Argo" or the "Company"), an international underwriter of specialty insurance and reinsurance products in the property and casualty market, today provided shareholders with an update...

Daniel O'Connor, President, Director & CEO of OncoSec Medical Incorporated (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today sent the following letter to shareholders. The full text of the...

MedMen Enterprises Inc. ("MedMen" or the "Company"), a leading cannabis retailer with operations across the U.S., today announced several financial arrangements and corporate updates that will strengthen the Company's balance sheet and enhance...

Dryden Capital Fund, LP and its affiliates (collectively, "Dryden" or "we"), a preferred shareholder of PIMCO Municipal Income Fund ("PMF"); PIMCO Municipal Income Fund II ("PML"); PIMCO Municipal Income Fund III ("PMX"); PIMCO New York Municipal...

Ortelius Advisors, L.P. (together with its affiliates, "Ortelius" or "we") announced today that it will vote against the proposed privatization (the "Bid") of Hudson's Bay Company ("Hudson's Bay," "HBC" or the "Company") by a consortium (the...

Enzo Biochem, Inc. , an integrated diagnostics and life sciences company focusing on delivering and applying advanced technology capabilities to produce affordable, reliable products and services that enable its customers to meet their clinical...

Hudson's Bay Company ("HBC" or the "Company") today mailed an informational brochure to remind all shareholders to vote FOR the transaction in which HBC will become a private company, owned by certain continuing shareholders (the "Continuing...

Hudson Executive Capital LP ("Hudson Executive") a New York-based investment firm and the largest shareholder of USA Technologies, Inc. ("USAT" or the "Company") with beneficial ownership of approximately 16.3% of common stock, today announced that...

OncoSec Medical Incorporated (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, released a video featuring its President and Chief Executive Officer, Daniel J. O'Connor, discussing why shareholders...

The Special Committee of the Board of Directors of Hudson's Bay Company ("HBC" or the "Company") today commented on the flawed report from Institutional Shareholder Services ("ISS") regarding the proposed transaction in which HBC will become a...